Trial Outcomes & Findings for Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU When Using Fast Gelling Dressing as Intended. (NCT NCT02091778)

NCT ID: NCT02091778

Last Updated: 2016-02-23

Results Overview

Measured by the following variables; maceration, redness/irritation, rash/eczema, blistering, dermatitis, skin stripping, trauma to wound edges and product degradation on the skin

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

21 participants

Primary outcome timeframe

12 weeks

Results posted on

2016-02-23

Participant Flow

Participant milestones

Participant milestones
Measure
Fast Gelling Dressing
Fast gelling dressing
Overall Study
STARTED
21
Overall Study
COMPLETED
20
Overall Study
NOT COMPLETED
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU When Using Fast Gelling Dressing as Intended.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Fast Gelling Dressing
n=21 Participants
Fast gelling dressing
Age, Continuous
59.9 years
STANDARD_DEVIATION 12.1 • n=99 Participants
Sex: Female, Male
Female
0 Participants
n=99 Participants
Sex: Female, Male
Male
21 Participants
n=99 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
Race (NIH/OMB)
Asian
0 Participants
n=99 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=99 Participants
Race (NIH/OMB)
White
21 Participants
n=99 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
Region of Enrollment
United Kingdom
21 participants
n=99 Participants

PRIMARY outcome

Timeframe: 12 weeks

Population: number of patients with healthy/intact peri-wound skin that increased from baseline to final visit. (From 6 to 14)

Measured by the following variables; maceration, redness/irritation, rash/eczema, blistering, dermatitis, skin stripping, trauma to wound edges and product degradation on the skin

Outcome measures

Outcome measures
Measure
Fast Gelling Dressing
n=21 Participants
Fast gelling dressing
Change in Peri-wound Skin
8 participants

Adverse Events

Fast Gelling Dressing

Serious events: 2 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Fast Gelling Dressing
n=21 participants at risk
Fast gelling dressing
Endocrine disorders
abdominal pain & pain in abdomen.
9.5%
2/21 • Number of events 2
Infections and infestations
high temperature and un-well,
4.8%
1/21 • Number of events 1

Other adverse events

Other adverse events
Measure
Fast Gelling Dressing
n=21 participants at risk
Fast gelling dressing
Infections and infestations
Infection to ulcer site,
4.8%
1/21 • Number of events 1

Additional Information

Paul Chadwick

Podiatry and Foot health, Stott Lane Salford ,UK

Phone: 0161 206 4710

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place